416 related articles for article (PubMed ID: 33994512)
1. A Rare Case of Reversible Cardiac Dysfunction Associated with Tegafur/Gimeracil/Oteracil (S-1) Therapy.
Oyakawa T; Hua Z; Ebihara A; Shiga T
Int Heart J; 2021 May; 62(3):700-705. PubMed ID: 33994512
[TBL] [Abstract][Full Text] [Related]
2. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
[TBL] [Abstract][Full Text] [Related]
3. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1).
Park YJ; Soh BW; Lee ES
Eur J Dermatol; 2017 Apr; 27(2):209-210. PubMed ID: 28251899
[No Abstract] [Full Text] [Related]
4. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
Wang HF; Lv JQ
Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
[TBL] [Abstract][Full Text] [Related]
5. [Tegafur/gimeracil/oteracil (Teysuno), by oral administration].
Duh D; Warnez M
J Pharm Belg; 2013 Dec; (4):35-6. PubMed ID: 24449972
[No Abstract] [Full Text] [Related]
6. Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome.
Matsuda K; Namiki T; Ueno M; Hashimoto T; Hanafusa T; Yokozeki H
Eur J Dermatol; 2017 Jun; 27(3):323-325. PubMed ID: 28414195
[No Abstract] [Full Text] [Related]
7. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
Wan Y; Hui H; Wang X; Wu J; Sun S
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG).
Chollet P; Schöffski P; Weigang-Köhler K; Schellens JH; Cure H; Pavlidis N; Grünwald V; De Boer R; Wanders J; Fumoleau P;
Eur J Cancer; 2003 Jun; 39(9):1264-70. PubMed ID: 12763215
[TBL] [Abstract][Full Text] [Related]
9. [A case of sclerosing cholangitis caused by oral chemotherapy with S-1].
Morisaki T; Ohnita K; Takeshima F; Akazawa Y; Yamaguchi N; Miyaaki H; Taura N; Ichikawa T; Isomoto H; Toriyama H; Nakao K
Nihon Shokakibyo Gakkai Zasshi; 2011 Feb; 108(2):245-52. PubMed ID: 21307629
[TBL] [Abstract][Full Text] [Related]
10. The Capsule Endoscopy Findings in S-1-induced Enteritis with Severe Diarrhea during Adjuvant Chemotherapy for Gastric Cancer (with Video).
Ota K; Takeuchi T; Kodama K; Ozaki H; Harada S; Kojima Y; Nouda S; Goto M; Higuchi K
Intern Med; 2018 Feb; 57(3):343-344. PubMed ID: 29093427
[TBL] [Abstract][Full Text] [Related]
11. [A case of postoperative chestwall recurrence of gastric cancer responding to a combination of radiation, hyperthermia and oral administration of TS-1].
Aotake T; Yamamoto H; Tanaka F; Fujii H; Hirose Y; Matsushita T
Gan To Kagaku Ryoho; 2004 Mar; 31(3):407-9. PubMed ID: 15045950
[TBL] [Abstract][Full Text] [Related]
12. Eccrine squamous syringometaplasia of underlying syringoma associated with Tegafur/Gimeracil/Oteracil (TS-1).
Kim J; Kim SH; Lee MG; Chung KY; Kim DS
Acta Derm Venereol; 2015 Nov; 95(8):999-1000. PubMed ID: 25766447
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients.
Wang T; Zhang SF; Qiu MQ; Li QL
Cancer Radiother; 2016 May; 20(3):181-6. PubMed ID: 27068497
[TBL] [Abstract][Full Text] [Related]
14. Tegafur + gimeracil + oteracil. Just another fluorouracil precursor.
Prescrire Int; 2013 May; 22(138):122. PubMed ID: 23819172
[TBL] [Abstract][Full Text] [Related]
15. Safe administration of S-1 after 5-fluorouracil-induced cardiotoxicity in a patient with colorectal cancer.
Franck C; Malfertheiner P; Venerito M
BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536214
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Rhabdomyolysis Related to SOX Therapy for Liver Metastasis of Gastric Cancer].
Sato K; Akiyama H; Kogure Y; Suwa Y; Momiyama M; Ishibe A; Endo I
Gan To Kagaku Ryoho; 2017 Apr; 44(4):329-331. PubMed ID: 28428515
[TBL] [Abstract][Full Text] [Related]
17. [A case of drug-induced pulmonary injury showing organizing pneumonia pattern due to S-1].
Nakata H; Shinano H; Kuraya D; Fujioka Y
Gan To Kagaku Ryoho; 2012 Jun; 39(6):955-7. PubMed ID: 22705691
[TBL] [Abstract][Full Text] [Related]
18. [A patient with recurrent gastric cancer who developed TS-1 induced hand-foot syndrome].
Arai K; Iwasaki Y; Kimura Y; Takahashi K; Yamaguchi T; Honma S; Takahashi T
Gan To Kagaku Ryoho; 2003 May; 30(5):699-702. PubMed ID: 12795105
[TBL] [Abstract][Full Text] [Related]
19. Safety of alternate-day treatment with TS-1
Nishiyama Y; Fukuyama Y; Maruo T; Yoda S; Iwano M; Kawarai S; Kayanuma H; Orito K
J Vet Med Sci; 2021 Aug; 83(8):1206-1211. PubMed ID: 34148911
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer.
Baba H; Yamamoto M; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T
Gastric Cancer; 2003; 6 Suppl 1():45-9. PubMed ID: 12775020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]